199 related articles for article (PubMed ID: 30186837)
1. Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective Study.
Ito T; Konishi A; Tsubokura Y; Azuma Y; Hotta M; Yoshimura H; Nakanishi T; Fujita S; Nakaya A; Satake A; Ishii K; Nomura S
Front Nutr; 2018; 5():72. PubMed ID: 30186837
[TBL] [Abstract][Full Text] [Related]
2. Ninjin'yoeito reduces fatigue-like conditions by alleviating inflammation of the brain and skeletal muscles in aging mice.
Otsuka S; Matsuzaki R; Kakimoto S; Tachibe Y; Kawatani T; Takada S; Tani A; Nakanishi K; Matsuoka T; Kato Y; Inadome M; Nojima N; Sakakima H; Mizuno K; Matsubara Y; Maruyama I
PLoS One; 2024; 19(5):e0303833. PubMed ID: 38768175
[TBL] [Abstract][Full Text] [Related]
3. Safety and Effectiveness of Ninjin'yoeito: A Utilization Study in Elderly Patients.
Suzuki S; Aihara F; Shibahara M; Sakai K
Front Nutr; 2019; 6():14. PubMed ID: 30873411
[TBL] [Abstract][Full Text] [Related]
4. Impact of
Okada KI; Kawai M; Hirono S; Miyazawa M; Kitahata Y; Kobayashi R; Ueno M; Hayami S; Shimokawa T; Yamaue H
Curr Ther Res Clin Exp; 2020; 93():100605. PubMed ID: 33014206
[TBL] [Abstract][Full Text] [Related]
5. Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma.
Gay F; Vincent Rajkumar S; Falco P; Kumar S; Dispenzieri A; Petrucci MT; Gertz MA; Boccadoro M; Keith Stewart A; Palumbo A
Eur J Haematol; 2010 Sep; 85(3):200-8. PubMed ID: 20477865
[TBL] [Abstract][Full Text] [Related]
6. Ninjin'yoeito, a traditional Japanese medicine, increases dopamine content in PC12 cells.
Miyazaki S; Omiya Y; Mizoguchi K
Biosci Biotechnol Biochem; 2021 Oct; 85(11):2274-2280. PubMed ID: 34529031
[TBL] [Abstract][Full Text] [Related]
7. Improvement in Frailty in a Patient With Severe Chronic Obstructive Pulmonary Disease After Ninjin'yoeito Therapy: A Case Report.
Kuniaki H; Akihiko T; Tetsuya H; Hatsuko M; Tomoko K; Shin O; Sojiro K; Mayumi Y; Fumihiro Y; Shintaro S; Tsukasa O; Hironori S
Front Nutr; 2018; 5():71. PubMed ID: 30234120
[TBL] [Abstract][Full Text] [Related]
8. Effects of Ninjin'yoeito on Patients with Chronic Obstructive Pulmonary Disease and Comorbid Frailty and Sarcopenia: A Preliminary Open-Label Randomized Controlled Trial.
Ohbayashi H; Ariga M; Ohta K; Kudo S; Furuta O; Yamamoto A
Int J Chron Obstruct Pulmon Dis; 2024; 19():995-1010. PubMed ID: 38737191
[TBL] [Abstract][Full Text] [Related]
9. Ninjin'yoeito Targets Distinct Ca
Goswami C; Dezaki K; Wang L; Inui A; Seino Y; Yada T
Front Nutr; 2020; 7():104. PubMed ID: 32766273
[TBL] [Abstract][Full Text] [Related]
10. Disuse muscle atrophy-improving effect of ninjin'yoeito in a mouse model.
Takemoto R; Sejima T; Han LK; Michihara S; Takahashi R
Neuropeptides; 2021 Dec; 90():102199. PubMed ID: 34610544
[TBL] [Abstract][Full Text] [Related]
11. Addition of Cyclophosphamide "On Demand" to Lenalidomide and Corticosteroids in Patients With Relapsed/Refractory Multiple Myeloma-A Retrospective Review of a Single-center Experience.
Alahmadi M; Masih-Khan E; Atenafu EG; Chen C; Kukreti V; Tiedemann R; Trudel S; Reece DE
Clin Lymphoma Myeloma Leuk; 2019 Apr; 19(4):e195-e203. PubMed ID: 30723035
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the Effects of Ninjin'yoeito on Physical Frailty in Mice.
Otsuka S; Fukumaru K; Tani A; Takada S; Kikuchi K; Norimatsu K; Matsuzaki R; Matsuoka T; Sakakima H; Omiya Y; Mizuno K; Matsubara Y; Maruyama I
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232484
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Efficacy of Ninjin'yoeito Treatment for Idiopathic Pulmonary Fibrosis.
Kushima H; Ishii H; Fujita M
Front Nutr; 2021; 8():548076. PubMed ID: 33996870
[TBL] [Abstract][Full Text] [Related]
14. Retrospective evaluation of the effect of Ninjin'yoeito in hepatocellular carcinoma patients treated with lenvatinib.
Toshida K; Itoh S; Yoshizumi T; Shimagaki T; Wang H; Kurihara T; Toshima T; Nagao Y; Harada N; Hata K; Makihara Y; Watanabe H; Mori M
Surg Today; 2022 Mar; 52(3):441-448. PubMed ID: 34417867
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study on the efficacy of Ninjin'yoeito on fatigue in patients with interstitial pneumonia.
Kushima H; Kinoshita Y; Fujita M; Ishii H
Neuropeptides; 2021 Oct; 89():102178. PubMed ID: 34298370
[TBL] [Abstract][Full Text] [Related]
16. Good Rehabilitation Outcomes and Improved Nutritional Status After Treatment With the Japanese Herbal Medicine Ninjin'yoeito in an Elderly Patient With Hip Fracture and Sarcopenia: A Case Report.
Morinaga A; Nakamura H; Hattanmaru K; Rokot NT; Kimura Y; Ito T
Front Nutr; 2020; 7():85. PubMed ID: 32714940
[TBL] [Abstract][Full Text] [Related]
17. Case Report: Ninjin'yoeito May Improve Quality of Life After Hospitalization for Acute Illness in Patients With Frailty.
Kashima M
Front Nutr; 2021; 8():547512. PubMed ID: 33937301
[No Abstract] [Full Text] [Related]
18. Herbal Medicine Ninjin'yoeito in the Treatment of Sarcopenia and Frailty.
Uto NS; Amitani H; Atobe Y; Sameshima Y; Sakaki M; Rokot N; Ataka K; Amitani M; Inui A
Front Nutr; 2018; 5():126. PubMed ID: 30619872
[TBL] [Abstract][Full Text] [Related]
19. How lenalidomide is changing the treatment of patients with multiple myeloma.
Dimopoulos MA; Terpos E; Niesvizky R
Crit Rev Oncol Hematol; 2013 Oct; 88 Suppl 1():S23-35. PubMed ID: 23816163
[TBL] [Abstract][Full Text] [Related]
20. Lenalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of a non-interventional study and comparison with the pivotal phase 3 clinical trials.
Knauf W; Aldaoud A; Losem C; Mittermueller J; Neise M; Niemeier B; Harde J; Trarbach T; Potthoff K
Leuk Res; 2018 May; 68():90-97. PubMed ID: 29579627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
